Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
Bioavailability |
62.5 |
% |
60-65 |
% |
|
DRUGBANK |
Bioavailability |
62.5 |
% |
60-65 |
% |
PO, oral; |
The Pharmacological Basis of Therapeutics |
C Max |
1600.0 |
ng/ml |
1.6 |
mcg/ml |
Oral single dose; |
The Pharmacological Basis of Therapeutics |
T Max |
4.0 |
h |
4.0 |
h |
Oral single dose; |
The Pharmacological Basis of Therapeutics |
Clearance |
4.6 |
L/h |
62-90 |
ml/min |
Plasma clearance; |
DRUGBANK |
Clearance |
0.0654 |
L/h/kg |
0.89-1.29 |
ml/min/kg |
hydrolysis; |
The Pharmacological Basis of Therapeutics |
Clearance |
0.0600 |
L/h/kg |
1 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
70.0 |
L |
70.0 |
L |
|
DRUGBANK |
Volume of Distribution |
1.0 |
L/kg |
1.0 |
L/kg |
hydrolysis; |
The Pharmacological Basis of Therapeutics |
Volume of Distribution |
0.94 |
L/kg |
0.94 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Half-life |
11.0 |
h |
9-13 |
h |
|
DRUGBANK |
Half-life |
11.0 |
h |
9-13 |
h |
|
The Pharmacological Basis of Therapeutics |
Half-life |
13.0 |
h |
13 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Eliminate Route |
0 |
% |
~0 |
% |
Urinary excretion; Unchanged drug; |
The Pharmacological Basis of Therapeutics |
Protein Binding |
95.0 |
% |
>95 |
% |
|
DRUGBANK |
Protein Binding |
95.0 |
% |
>95 |
% |
|
The Pharmacological Basis of Therapeutics |